New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
December 20, 2012
10:11 EDTCDE, TROV, PDCO, SNSS, RLOC, TAP, FANG, PRAN, PBCT, LXP, IEC, BREW, BLK, ABT, LNCO, HTA, CPTS, SAM, INXN, DVA, CNSI, ARRYOn The Fly: Analyst Initiation Summary
Today's noteworthy initiations include: Abbott (ABT) initiated with an Outperform at William Blair... Array BioPharma (ARRY) initiated with an Outperform at Wells Fargo... BlackRock (BLK) initiated with an Overweight at JPMorgan... Boston Beer (SAM) initiated with a Neutral at Citigroup... Comverse (CNSI) initiated with a Neutral at JPMorgan... Conceptus (CPTS) initiated with a Buy at Stifel Nicolaus... Craft Brew (BREW) initiated with a Neutral at Citigroup... DaVita (DVA) initiated with an Overweight at JPMorgan... Healthcare Trust (HTA) initiated with an Outperform at Wells Fargo... IEC Electronics (IEC) initiated with a Buy at C.K. Cooper... InterXion (INXN) initiated with a Neutral at Goldman... Lexington Realty (LXP) initiated with a Buy at Jefferies... LinnCo (LNCO) initiated with an Outperform at Wells Fargo... Molson Coors (TAP) initiated with a Neutral at Citigroup... Patterson Companies (PDCO) initiated with a Buy at Stifel Nicolaus... People's United (PBCT) initiated with an Underweight at Evercore... ReachLocal (RLOC) initiated with a Buy at Janney Capital... Sunesis (SNSS) initiated with an Outperform at Wells Fargo... Trovagene (TROV) initiated with a Buy at Roth Capital... Prana (PRAN) initiated with an Outperform at Burrill... Coeur d’Alene Mines (CDE) initiated with an Accumulate at Global Hunter... Diamondback Energy (FANG) initiated with a Market Perform at Raymond James.
News For ABT;ARRY;SAM;BLK;CNSI;CPTS;BREW;DVA;HTA;IEC;INXN;LNCO;LXP;TAP;PDCO;PBCT;RLOC;TROV;PRAN;SNSS;CDE;FANG From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
July 2, 2015
08:13 EDTTAPMolson Coors U.K. acquires 'Rekorderlig U.K.'
Subscribe for More Information
July 1, 2015
09:01 EDTPDCOPatterson Companies to sell medical business to Madison Dearborn for $715M
Subscribe for More Information
07:03 EDTFANGDiamondback Energy initiated with an Overweight at Stephens
Subscribe for More Information
05:14 EDTPRANPrana announces safety outcomes of Alzheimer's IMAGINE extension trial
Subscribe for More Information
June 30, 2015
09:02 EDTCDECoeur Mining price target raised to $7.25 from $6.50 at Roth Capital
After visiting Coeur's Rochester and Wharf mines, Roth Capital is impressed with what it sees as the company's operational improvements at Rochester and the resource growth potential at Wharf. The firm keeps a Buy rating on the stock.
June 25, 2015
12:52 EDTABTEU to decide by July 29 on Mylan's bid for Perrigo, Reuters reports
Subscribe for More Information
10:11 EDTARRYOptions with decreasing implied volatility
Subscribe for More Information
10:00 EDTLXPOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
09:10 EDTLXPLexington Realty downgraded to Neutral from Buy at BofA/Merrill
Subscribe for More Information
07:37 EDTINXNANI Pharmaceuticals mentioned positively by Oscar Schafer
Subscribe for More Information
June 24, 2015
06:46 EDTCDECoeur Mining reports 39% increase in Wharf’s gold reserves
Subscribe for More Information
06:32 EDTDVADaVita discloses it received subpoena from Inspector General
In a regulatory filing, DaVita disclosed that the company recently received a subpoena from the Office of Inspector General, U.S. Department of Health and Human Services. This civil subpoena covers the period from January 1, 2008 through the present and seeks production of a wide range of documents relating to the company’s and its subsidiaries’ provision of services to Medicare Advantage plans and Medicare Advantage organizations and related patient diagnosis coding and risk adjustment submissions and payments. DaVita believes that the request is part of a broader industry investigation into Medicare Advantage patient diagnosis coding and risk adjustment practices and potential overpayments by the government. In the event that the company were to incur liability related to this matter, the company would pursue an indemnification claim against the sellers secured by the escrow. We can make no assurances that the indemnification and escrow would cover the full amount of our potential losses related to this matter. The company is cooperating with the government and will gather and produce the requested information.
06:30 EDTDVADaVita discloses Robert Margolis not re-nominated as co-chairman of company
Subscribe for More Information
June 23, 2015
10:30 EDTARRYOptions with decreasing implied volatility
Subscribe for More Information
10:00 EDTTAPOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
07:59 EDTBLKCFA Society of Minnesota to hold a discussion
Subscribe for More Information
07:44 EDTTAPMolson Coors downgraded to Neutral at Nomura
As previously reported, Nomura downgraded Molson Coors to Neutral from Buy and lowered its price target to $74 from $82. The firm believes U.S. volume and pricing trends have worsened year-to-date and lowered its probability the company will buy the rest of MillerCoors in the U.S.
07:24 EDTLNCOCredit Suisse to hold a conference
Subscribe for More Information
05:27 EDTTAPMolson Coors downgraded to Neutral from Buy at Nomura
Subscribe for More Information
June 19, 2015
05:55 EDTARRYPiper sees 'transformative' two years for Array BioPharma
Piper Jaffray analyst Edward Tenthoff expects the next two years to be "transformative" for Array BioPharma (ARRY), with the company reporting pivotal data and likely gaining approval on wholly-owned MEK inhibitor binimetinib and BRAF inhibitor encorafenib. In addition, partner AstraZeneca (AZN) will report selumetinib data in uveal melanoma and file a new drug application this year resulting in royalty revenue to Array in 2016, the analyst tells investors today in a research note. Tenthoff reiterates an Overweight rating on the stock with a $15 price target.
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use